Description
Technical & Manufacturing Relevance:
Essential for DNA and RNA synthesis, cell division, and tissue growth
Critical for red blood cell formation and prevention of megaloblastic anemia
Plays a key role in homocysteine metabolism and cardiovascular health
Mandatory nutrient in prenatal and maternal nutrition to reduce neural tube defect risk
Widely used in multivitamin, prenatal, hematinic, and food-fortification formulations
Highly stable compared to reduced folates, making it ideal for manufacturing and long shelf life
Applicable Dosage Forms:
Tablets and capsules
Powders, granules, and sachets
Oral liquids and syrups
Multivitamin and B-complex premixes
Prenatal and maternal nutrition products
Fortified foods and nutritional beverages
Pharmacopoeial / Quality Notes:
Available in grades compliant with USP / EP / BP / IP / FCC
Yellow to orange-yellow crystalline powder
Slightly soluble in water; soluble in dilute alkali solutions
Stable under normal processing and storage conditions; sensitive to light
Manufactured in GMP-certified facilities with full batch traceability
Animal-Origin Declaration:
100% non-animal origin
Free from BSE/TSE, GMO, and allergen risks
Manufacturing Support:
Supplied with COA, SDS/MSDS, TDS, specification sheet, assay method, and origin declaration
Technical support for folate equivalence calculations, formulation stability, and label claim compliance
Regulatory and documentation support available for global resale, export, and international distribution
Suitable for pharmaceutical, nutraceutical, food supplement, and healthcare product manufacturing worldwide, subject to local regulatory approvals
Important Note:
N-Pteroyl-L-glutamic acid (folic acid) is a globally accepted and highly stable form of vitamin B9. Final dosage and claims must comply with country-specific folate RDA and UL limits, especially in prenatal and food-fortification applications, to ensure safety and regulatory acceptance.
